Cagrilintide 10mg

Cagrilintide is a long-acting amylin-analogue research peptide used in controlled in-vitro studies of amylin-receptor pharmacology (calcitonin receptor/RAMP complexes), second-messenger signalling, and peptide structure–activity relationships under non-clinical laboratory conditions.

Cagrilintide — 10 mg | Research Use Only

This listing provides a 10 mg vial of cagrilintide as a lyophilised solid for cell-based and biochemical model systems. Investigations focus on molecular mechanisms and assay readouts only.
For laboratory research only. Not for human use.

Key features

• Amylin-receptor peptide analogue for in-vitro receptor-signalling and SAR studies.
• Designed for studies involving calcitonin receptor (CALCR) with RAMP1/2/3 co-receptors.
• Supplied as a lyophilised solid for straightforward handling and storage.
• Unit size: 10 mg per vial.
• Each batch released after stringent internal quality checks.

Specifications for Cagrilintide

• Product name: Cagrilintide
• Synonyms: Long-acting amylin analogue (research-grade)
• Class: Peptide analogue (amylin receptor)
• Form: Lyophilised powder
• Appearance: White to off-white solid
• Note: Counter-ion/hydration state may vary. Refer to the vial label for lot-specific details.

Handling & storage of Cagrilintide

1. Storage (dry): Keep vials at 2–8 °C, protected from light and moisture.
2. Reconstitution: For step-by-step guidance, see our internal guide:
   Reconstituting & Storage.
3. After reconstitution: Store at 2–8 °C, protect from light, use aliquots to reduce handling, and avoid repeated temperature cycling.
4. Compatibility: Use only within research protocols that follow your lab’s SOPs and local regulations.

Looking for complementary materials? See
Bacteriostatic Water 10 ml and related metabolic-pathway research companions such as
XL-R3TA 25 mg and
NAD+.

About cagrilintide in research

Researchers use cagrilintide to probe amylin-receptor engagement (CALCR/RAMP complexes), map downstream second-messenger responses, and compare potency/selectivity versus related peptide analogues—exclusively in controlled, non-clinical in-vitro environments.

Synthesis & quality

Manufactured via controlled, validated peptide-synthesis processes to deliver high purity and lot-to-lot consistency. Each batch undergoes identity, purity, and appearance checks before release.